Home > Cardiology > ACC 2021 > Letter from the Editor

Letter from the Editor

Prof. Marc Bonaca, University of Colorado, USA
ACC 2021
Dear Colleagues, We thank you for your interest in this edition of Medicom’s Conference Reports focused on the 2021 American College of Cardiology (ACC) Annual Scientific Sessions. This year’s ACC meeting was rich with late-breaking presentations and cutting-edge science. Topics ranging from heart failure, vascular medicine, electrophysiology, and COVID 19 are covered. Late-breaking trials including PARADISE MI, DARE, REHAB-HF presented their primary results and are described in the following concise summaries. Important clinical trial updates including the total burden of vascular events in VOYAGER PAD and sex and outcomes from TWILIGHT are also presented. We hope you find the following pages to be informative, concise, and balanced as our editorial team constantly strives to produce the highest quality summaries. Most of all, we hope you and your families are safe and healthy, we thank you for your contributions through this difficult time, and we hope to s...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on